Biweekly paclitaxel plus gemcitabine in advanced breast cancer: phase II trial and predictive value of HER2 extracellular domain
2004 ◽
Vol 15
(2)
◽
pp. 201-206
◽
R. Colomer
◽
A. Llombart-Cussac
◽
A. Lluch
◽
A. Barnadas
◽
B. Ojeda
◽
...
2007 ◽
Vol 46
(2)
◽
pp. 208-213
◽
Herbert Ulrich-Pur
◽
Gabriela V. Kornek
◽
Karin Haider
◽
Werner Kwasny
◽
Thomas Payrits
◽
...
1986 ◽
Vol 9
(4)
◽
pp. 236-238
◽
H.-E. Wander
◽
D. Meyer
◽
P. Schuff-Werner
◽
G.A. Nagel
G. Mathe
◽
R. Helling
◽
J. Gastlaburu
◽
M.L.. VoVan
◽
G. Prévot
◽
...
2008 ◽
Vol 8
(3)
◽
pp. 257-263
◽
John T. Hamm
◽
John W. Wilson
◽
Priya Rastogi
◽
Barry C. Lembersky
◽
George C. Tseng
◽
...
L Mauriac
◽
D Cameron
◽
L Dirix
◽
E Blot
◽
M Piccart
◽
...
E Mrozek
◽
LJ Schaaf
◽
B Ramaswamy
◽
D Shiels
◽
L Houton
◽
...
DA Yardley
◽
NW Peacock
◽
JD Hainsworth
◽
III HA Burris
AS Clark
◽
P Lal
◽
KS Tan
◽
DF Heitjan
◽
M Feldman
◽
...
1986 ◽
Vol 4
(1)
◽
pp. 39-42
◽
Massimo Lopez
◽
Luigi Di Lauro
◽
Paola Papaldo
◽
Bonaventura Lazzaro
◽
Fabrizio Ganzina
◽
...
2008 ◽
Vol 75
(3-4)
◽
pp. 175-181
◽
Patrizia Vici
◽
Luigi Di Lauro
◽
Domenico Sergi
◽
Paolo Foggi
◽
Giuditta Viola
◽
...